PX-1031 (Pharmexa)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePX-1031 (Pharmexa)
Drug Alias NameME-103.1.1PX-103.1PX-1031ME-103
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulantsReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharmexa As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmexa As
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A